# FORDOZ PHARMA CORPORATION – FDA Inspection, Nov 12, 2025

Source: https://www.keypedia.com/records/fda_inspections/fordoz-pharma-corporation/f74f11d4-45af-4ab0-a6c7-ad42a05f6193
Source feed: FDA_Inspections

> FDA inspection 1291050 of FORDOZ PHARMA CORPORATION, November 12, 2025. Classification: Official Action Indicated (OAI). 9 citations under 21 CFR part 211. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1291050
- Company Name: FORDOZ PHARMA CORPORATION
- Inspection Date: 2025-11-12
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New Jersey District Office
- Citation Count: 9

## Related Documents

- [FDA Inspection 1201660 - 2023-03-17](https://www.keypedia.com/records/fda_inspections/fordoz-pharma-corporation/00df13bf-d33e-4cb4-9e1d-9e893134df59)

## Related Officers

- [Ankur C. Patel](https://www.keypedia.com/people/ankur-c-patel/602c7d14-2c48-4929-a07b-6e4c235d7f13)
- [Investigator](https://www.keypedia.com/people/vivin-george/0b0ee298-a577-4bee-b18e-42da0c3bb148)

Company: https://www.keypedia.com/companies/fordoz-pharma-corporation/d5bae860-733e-4866-86c1-e97c3087f8af

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248